3 ms·
An interesting move into therapeutics, from their previous main business in diagnostics. I wonder how much due diligence the new investors did.
by sprague 8y ago
An interesting move into therapeutics, from their previous main business in diagnostics. I wonder how much due diligence the new investors did.